Reduce the Incidence of HIV

A crucial component of ending the HIV/AIDS epidemic is the development, evaluation and implementation strategies to successfully prevent new infections. ERC-CFAR investigators advance the high priority of the NIH for HIV research, to reduce the incidence of HIV, by developing and testing safe, effective, and affordable biomedical interventions in parallel with establishing and evaluating novel behavioral and social science-based prevention approaches. Our investigators are developing strategies to enhance expanding the uptake and adherence of pre-exposure prophylaxis (PrEP), reduce stigma associated with treatment, expand product delivery options, and implement effective HIV prevention packages. They are also determining the impact of mucosal and microbiome environments on the effectiveness of HIV prevention interventions, as well as evaluating the effectiveness of new strategies for the early diagnosis of infection, such as low-cost self or home testing, to stimulate early initiation into care. Listed below are NIH-funded studies by ERC-CFAR Investigators researching strategies to reduce the incidence of HIV.